22 November 2022 : Clinical Research
Macronutrients Management for Growth in Neonates with Congenital Gastrointestinal Malformation
Timea E. Brandibur12AC, Aniko Maria Manea12AF, Abhinav Sharma
345BDE, Nilima Rajpal Kundnani 56AE*, Marius Călin Popoiu7D, Bilal Ahmad8B, Diala S. Dahdal 8DEF, Daniela Cioboata2C, Nicoleta Lungu12A, Florina Marinela Doandes12F, Eugen Radu Boia9F, Marioara D. Boia12AD
DOI: 10.12659/MSM.938106
Med Sci Monit 2022; 28:e938106
Table 2 Characteristics of the newborns with atresia versus the control group.
| Characteristic | OverallN=51* | AtresiaN=17* | Control atresiaN=34* | p-value** |
|---|---|---|---|---|
| Sex | >0.9 | |||
| F | 12 (24%) | 4 (24%) | 8 (24%) | |
| M | 39 (76%) | 13 (76%) | 26 (76%) | |
| Weight: baseline | 3,160 (2,400, 3,420) | 3,160 (2,400, 3,400) | 3,160 (2,400, 3,420) | >0.9 |
| Weight: discharge | 3,120 (2,890, 3,645) | 3,000 (2,750, 3,600) | 3,155 (2,980, 3,675) | 0.3 |
| Difference (weight) | 220 (90, 490) | 110 (0, 330) | 265 (102, 552) | 0.089 |
| LOS (days) | 9 (5, 15) | 6 (3, 14) | 10 (7, 15) | 0.050 |
| Gestation | >0.9 | |||
| Preterm | 15 (29%) | 5 (29%) | 10 (29%) | |
| IUGR | 9 (18%) | 3 (18%) | 6 (18%) | |
| Term | 27 (53%) | 9 (53%) | 18 (53%) | |
| Nutrition | 0.8 | |||
| BM | 31 (61%) | 10 (59%) | 21 (62%) | |
| FM | 20 (39%) | 7 (41%) | 13 (38%) | |
| GR | 21 (41%) | 10 (59%) | 11 (32%) | 0.070 |
| Vomiting | 14 (27%) | 13 (76%) | 1 (2.9%) | <0.001 |
| Abdominal distension | 16 (31%) | 13 (76%) | 3 (8.8%) | <0.001 |
| * n (%); Median (IQR); ** Fisher’s exact test; Wilcoxon rank sum test; Pearson’s Chi-squared test; LOS – length of stay (days); IUGR – intra-uterine growth retardation; BM – breast milk; FM – formula milk; GR – gastric residuals. | ||||